The potential role for lixivaptan in heart failure and in hyponatremia

Author： Zmily Hammam D   Khan Nazia S   Daifallah Suleiman   Ghali Jalal K  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.6, 2011-06, pp. : 831-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of lixivaptan in euvolemic and hypervolemic hyponatremia and heart failure treatment

By Zmily Hammam D   Alani Anas   Ghali Jalal K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 645-655

Informa Healthcare

Access to resources Recommend Favorite

Lixivaptan may be effective in reducing water retention associated with heart failure

By  

Inpharma, Vol. 1, Iss. 1538, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Diastolic Heart Failure in the Elderly and the Potential Role of Aldosterone Antagonists

By Kumar Ashwani  

Drugs & Aging, Vol. 23, Iss. 4, 2006-01 ,pp. : 299-308

Adis International

Access to resources Recommend Favorite

The potential role of valsartan + AHU377 (LCZ696) in the treatment of heart failure

By Voors Adriaan A  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 8, 2013-08 ,pp. : 1041-1047

Informa Healthcare

Access to resources Recommend Favorite

Potential Role of Inflammation in Associations between Particulate Matter and Heart Failure

By  

Current Pharmaceutical Design, Vol. 24, Iss. 3, 2018-04 ,pp. : 341-358

Bentham Science Publishers

Access to resources Recommend Favorite